An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.
Previous studies found that allergies are inversely related to risk of glioma. In an earlier publication, using data from a Swedish case-control study, Schwartzbaum et al. report an inverse relation between risk of glioblastoma and four single nucleotide polymorphisms (SNP) on two genes [interleukin (IL)-4Ralpha, IL-13] that are associated with allergies. In addition, recent studies suggest that IL-4 and IL-13 induce cyclooxygenase-2 (COX-2) to resolve brain inflammation. To see whether previous Swedish results (110 cases, 430 controls) would be replicated, we estimated the association between glioblastoma and two IL-4Ralpha (rs1805015, rs1801275) and two IL-13 (rs20541, rs1800925) SNPs and their haplotypes and one COX-2 SNP (-765GC) using additional English, Danish, and Finnish data (217 cases, 1,171 controls). Among general population controls, we evaluated associations between these haplotypes, the COX-2 SNP, and self-reported allergies. Our data did not support our original observations relating individual IL-4Ralpha, IL-13, or COX-2 SNPs to glioblastoma risk. However, the T-G IL-4Ralpha haplotype was associated with glioblastoma risk (odds ratio, 2.26; 95% confidence interval, 1.13-4.52) and there was a suggestion of an inverse relation between this haplotype and hayfever prevalence among controls (odds ratio, 0.38; 95% confidence interval, 0.14-1.03). The lack of support for a link between four IL-4Ralpha and IL-13 SNPs and glioblastoma may reflect the absence of associations or may result from uncontrolled confounding by haplotypes related both to those that we examined and glioblastoma. Nonetheless, the association between the T-G IL-4Ralpha haplotype and glioblastoma risk may indicate a role of immune factors in glioblastoma development.
Schwartzbaum
Judith A
JA
Division of Epidemiology, School of Public Health, Ohio State University, Starling-Loving Hall, 320 West Tenth Avenue, Columbus, OH 43210, USA. schwartzbaum.1@osu.edu
Ahlbom
Anders
A
Lönn
Stefan
S
Malmer
Beatrice
B
Wigertz
Annette
A
Auvinen
Anssi
A
Brookes
Anthony J
AJ
Collatz Christensen
Helle
H
Henriksson
Roger
R
Johansen
Christoffer
C
Salminen
Tina
T
Schoemaker
Minouk J
MJ
Swerdlow
Anthony J
AJ
Debinski
Waldemar
W
Feychting
Maria
M
D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D051546:Cyclooxygenase 2 / Q000097:blood / Q000235:genetics*; D005060:Europe / Q000453:epidemiology; D005260:Female; D020022:Genetic Predisposition to Disease; D005909:Glioblastoma / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology; D006239:Haplotypes; D006801:Humans; D006967:Hypersensitivity / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics / Q000276:immunology; D018793:Interleukin-13 / Q000097:blood / Q000235:genetics*; D053662:Interleukin-4 Receptor alpha Subunit / Q000097:blood / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide
D018793:Interleukin-13; D053662:Interleukin-4 Receptor alpha Subunit; D051546:Cyclooxygenase 2